CY2116B1 - Bradykinin-antagonists for the treatment of acute pancreatitis - Google Patents

Bradykinin-antagonists for the treatment of acute pancreatitis

Info

Publication number
CY2116B1
CY2116B1 CY9800034A CY9800034A CY2116B1 CY 2116 B1 CY2116 B1 CY 2116B1 CY 9800034 A CY9800034 A CY 9800034A CY 9800034 A CY9800034 A CY 9800034A CY 2116 B1 CY2116 B1 CY 2116B1
Authority
CY
Cyprus
Prior art keywords
gly
hyp
pro
substituted
benzoyl
Prior art date
Application number
CY9800034A
Other languages
English (en)
Inventor
Thomas Dr Griesbacher
Fred Prof Dr Lembeck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CY2116B1 publication Critical patent/CY2116B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY9800034A 1991-12-21 1998-09-29 Bradykinin-antagonists for the treatment of acute pancreatitis CY2116B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91122055 1991-12-21

Publications (1)

Publication Number Publication Date
CY2116B1 true CY2116B1 (en) 2002-04-26

Family

ID=8207466

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9800034A CY2116B1 (en) 1991-12-21 1998-09-29 Bradykinin-antagonists for the treatment of acute pancreatitis

Country Status (27)

Country Link
US (1) US5670619A (fi)
EP (1) EP0548825B1 (fi)
JP (1) JP3588472B2 (fi)
KR (1) KR930012034A (fi)
CN (1) CN1073603A (fi)
AT (1) ATE152733T1 (fi)
AU (1) AU662188B2 (fi)
BG (1) BG97168A (fi)
BR (1) BR9205062A (fi)
CA (1) CA2085781C (fi)
CY (1) CY2116B1 (fi)
CZ (1) CZ375692A3 (fi)
DE (1) DE69219574T2 (fi)
DK (1) DK0548825T3 (fi)
ES (1) ES2101017T3 (fi)
FI (1) FI925782A (fi)
GR (1) GR3024179T3 (fi)
HU (1) HU214056B (fi)
IL (1) IL104163A0 (fi)
MA (1) MA22743A1 (fi)
MX (1) MX9207440A (fi)
NO (1) NO924925L (fi)
PL (1) PL297044A1 (fi)
SI (1) SI9200406A (fi)
TW (1) TW199863B (fi)
YU (1) YU108192A (fi)
ZA (1) ZA929829B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009010B1 (en) * 1978-07-18 1983-03-02 Kabi AB Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ES2101017T3 (es) 1997-07-01
ZA929829B (en) 1994-02-16
JPH05255107A (ja) 1993-10-05
AU662188B2 (en) 1995-08-24
FI925782A0 (fi) 1992-12-18
DE69219574D1 (de) 1997-06-12
BR9205062A (pt) 1993-09-28
MX9207440A (es) 1993-07-01
FI925782A (fi) 1993-06-22
JP3588472B2 (ja) 2004-11-10
EP0548825A1 (en) 1993-06-30
NO924925D0 (no) 1992-12-18
DK0548825T3 (da) 1997-11-03
TW199863B (fi) 1993-02-11
BG97168A (bg) 1993-12-24
CA2085781A1 (en) 1993-06-22
DE69219574T2 (de) 1997-11-13
PL297044A1 (en) 1993-09-06
CN1073603A (zh) 1993-06-30
SI9200406A (en) 1993-06-30
HU214056B (en) 1997-12-29
IL104163A0 (en) 1993-05-13
ATE152733T1 (de) 1997-05-15
YU108192A (sh) 1995-12-04
MA22743A1 (fr) 1993-07-01
NO924925L (no) 1993-06-22
GR3024179T3 (en) 1997-10-31
CA2085781C (en) 2003-09-23
EP0548825B1 (en) 1997-05-07
US5670619A (en) 1997-09-23
CZ375692A3 (en) 1993-12-15
HU9204074D0 (en) 1993-04-28
KR930012034A (ko) 1993-07-20
HUT63336A (en) 1993-08-30
AU3021292A (en) 1993-06-24

Similar Documents

Publication Publication Date Title
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
IL104314A0 (en) Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
DE69232636D1 (de) CNP-Analoge Peptide und ihre Verwendung
PL1755630T3 (pl) Kompozycje farmaceutyczne z brodaczki włosowatej i dziurawca oraz ich zastosowanie
FI956050A0 (fi) Biologisesti aktiiviset vasopressiinianalogit
ZA929829B (en) Bradykinin-antagonists for the treatment of acute pancreatitis
AU7935494A (en) Bivalent thrombin inhibitors
TW224975B (fi)
TH13940A (th) เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน
RU92016227A (ru) Лекарственная композиция, включающая антагонисты брадикинина, используемая в лечении острого панкреатита, способ ее получения и использование
TH13940EX (th) เบรดีไคนิน-แอนตาโกนิส สำหรับใช้บำบัดตับอ่อนอักเสบเฉียบพลัน
GR3015492T3 (en) ZNS-active hexapeptides with antiamnestic activity.
ES541194A0 (es) Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados.
WO1999043701A3 (en) Peptides for inhibition of apoptosis and pharmaceutical compositions containing them